Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

 
 
DownloadE-Mail
  Genetic variation and pharmacogenomics : concepts, facts, and challenges

Hoehe, M. R., & Kroslak, T. (2004). Genetic variation and pharmacogenomics: concepts, facts, and challenges. Dialogues in Clinical Neuroscience, 6(1), 5-25.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel
Alternativer Titel : Dialogues Clin Neurosci

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Hoehe, Margret R.1, Autor           
Kroslak, Thomas2, Autor
Affiliations:
1Genetic Variation, Haplotypes, and Genetics of Complex Disease (Margret Hoehe), Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1479651              
2Max Planck Society, ou_persistent13              

Inhalt

einblenden:
ausblenden:
Schlagwörter: genetic variation; DNA sequence; candidate gene; single nucleotide polymorphism; haplotype; drug response
 Zusammenfassung: The analysis of genetic variation in candidate genes is an issue of central importance in pharmacogenomics. The spe- cific approaches taken will have a critical impact on the successful identification of disease genes, the molecular cor- relates of drug response, and the establishment of meaningful relationships between genetic variants and phenotypes of biomedical and pharmaceutical importance in general. Against a historical background, this article distinguishes different approaches to candidate gene analysis, reflecting different stages in human genome research. Only recently has it become feasible to analyze genetic variation systematically at the ultimate level of resolution, ie, the DNA sequence. In this context, the importance of haplotype-based approaches to candidate gene analysis has at last been recognized; the determination of the specific combinations of variants for each of the two sequences of a gene defined as a haplotype is essential. An up-to-date summary of such maximum resolution data on the amount, nature, and struc- ture of genetic variation in candidate genes will be given. These data demonstrate abundant gene sequence and hap- lotype diversity. Numerous individually different forms of a gene may exist. This presents major challenges to the analy- sis of relationships between genetic variation, gene function, and phenotype. First solutions seem within reach. The implications of naturally occurring variation for pharmacogenomics and “personalized” medicine are now evident. Future approaches to the identification, evaluation, and prioritization of drug targets, the optimization of clinical tri- als, and the development of efficient therapies must be based on in-depth knowledge of candidate gene variation as an essential prerequisite.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2004
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: eDoc: 230220
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Dialogues in Clinical Neuroscience
  Alternativer Titel : Dialogues Clin Neurosci
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 6 (1) Artikelnummer: - Start- / Endseite: 5 - 25 Identifikator: ISSN: 1294-8322